The Technique of Skin Stretching for Acute Burn Treatment and Scar Reconstruction

June 25, 2015 updated by: Association of Dutch Burn Centres

The Technique of Skin Stretching for Acute Burn Treatment and Scar Reconstruction: Clinical Applications and Working Mechanisms.

Objective:

A randomized controlled trial is performed to evaluate the clinical effectiveness of the skin stretching technique for two categories:

  1. acute burn wounds: wound closure by means of skin stretching should lead to a significant reduction of scar surface area in comparison to the standard technique, the split skin grafting;
  2. scar reconstructions: wound closure by means of skin stretching during one operative procedure should lead to a comparable scar surface in comparison to the multiple procedures techniques such as serial excision.

Study design:

Skin stretching will be compared to split skin grafting and should result in burn wound closure with significantly smaller scars. Also, a comparison will be made between the technique of serial excision versus skin stretching for scar reconstructions.

Scar evaluation three and twelve months after surgery will include the following parameters:

  • surface area;
  • Patient and Observer Scar Assessment Scale (POSAS);
  • elasticity;
  • vascularization and pigmentation;
  • thickness;
  • dermal architecture.

After 12 months adults will undergo a biopsy of the scar under local anesthesia. The experimental group, treated with the skin stretcher will undergo one extra biopsy of the formerly stretched skin.

Intervention:

At the start of the operation will be determined by randomization if skin stretching or split skin grafting (acute burn wounds) or serial excision (scar reconstruction category) will be performed.

Study Overview

Detailed Description

Eligibility criteria:

Inclusion:

1. Acute Burn wounds or scar reconstructions that require surgical treatment; 2. Sufficient healthy skin at (at least) one edge of the wound/scar must be available for the stretching procedure.

3. Age >= 18 years

Exclusion:

  1. language barrier;
  2. known history of keloid formation;
  3. systemic diseases: Diabetes Mellitus, immunodeficiency, arterial insufficiency;
  4. local or systemic application of corticosteroids;
  5. psychiatric diseases leading to study bias (e.g. automutilation);
  6. skin diseases that lead to collagen and/or elastin abnormalities such as Ehlers Danlos;
  7. radiated skin;
  8. wound located at extremities, exceeding >33% of circumference (acute burn category);

Primary study parameters/outcome of the study:

The primary study parameter is the surface area of the scar after 12 months

Secondary study parameters/outcome of the study (if applicable):

All scars will also be subjected to the scar evaluation protocol after 3 and 12 months by an independent observer for the evaluation of the:

  • patient and observer scar assessment scale (POSAS);
  • scar elasticity (Cutometer);
  • scar vascularisation & pigmentation (DermaSpectrometer);
  • scar thickness (histopathology, only after 12 months).

Punch biopsies are taken for morphometry of dermal architecture (Fourier analysis). During surgery one biopsy is obtained of the normal skin. In the experimental group an additional biopsy is obtained at the end of the stretching procedure in order to be able to compare structure of the dermal matrix and orientation of the collagen fibers.

After 1 year, one biopsy is taken from the scar. The experimental group will undergo one additional biopsy of the formerly stretched skin.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Beverwijk, Netherlands
        • Red Cross Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria:

  • Acute Burn wounds or scar reconstructions that require surgical treatment;
  • Sufficient healthy skin at (at least) one edge of the wound/scar must be available for the stretching procedure;
  • Age >= 18 years.

Exclusion criteria:

  • Language barrier;
  • Known history of keloid formation;
  • Systemic diseases: Diabetes Mellitus, immunodeficiency, arterial insufficiency;
  • Local or systemic application of corticosteroids;
  • Psychiatric diseases leading to study bias (e.g. automutilation);
  • Skin diseases that lead to collagen and/or elastin abnormalities such as Ehlers Danlos;
  • Radiated skin;
  • Wound located at extremities, exceeding >33% of circumference (acute burn category).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: A1
Acute Burn Wounds: Wound debridement and split skin grafting
After wound bed preparation the skin defect is covered with a skin transplant (split skin graft)
Experimental: A2
Acute Burn Wounds: excision of the burn wound and primary closure, using a skin stretching device
after woundbed preparation the wound is primarily closed by aid of the skin stretching device
after the scar is excised, the wound is primarily closed by aid of the skin stretching device
Active Comparator: B1
Scar reconstruction: serial excision
as much scar as possible is excised, whereafter the wound is closed
Experimental: B2
Scar reconstruction: primary closure, using skin stretching device
after woundbed preparation the wound is primarily closed by aid of the skin stretching device
after the scar is excised, the wound is primarily closed by aid of the skin stretching device

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
the surface area of the scar after 12 months
Time Frame: 3 and 12 months after surgery
3 and 12 months after surgery

Secondary Outcome Measures

Outcome Measure
Time Frame
scar evaluation protocol: - patient and observer scar assessment scale (POSAS); - scar elasticity (Cutometer); - scar vascularization & pigmentation (DermaSpectrometer); - scar thickness
Time Frame: 3 and 12 months after surgery
3 and 12 months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: E Middelkoop, Professor, VU MC
  • Study Director: P.P.M. van Zuijlen, MD, PhD, Red Cross Hospital Beverwijk

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2007

Primary Completion (Actual)

June 1, 2011

Study Completion (Actual)

June 1, 2011

Study Registration Dates

First Submitted

January 25, 2008

First Submitted That Met QC Criteria

February 6, 2008

First Posted (Estimate)

February 7, 2008

Study Record Updates

Last Update Posted (Estimate)

June 26, 2015

Last Update Submitted That Met QC Criteria

June 25, 2015

Last Verified

June 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 06.201

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Burns

Clinical Trials on Split skin graft

3
Subscribe